Evaluation of myocardial viability by MRI

被引:46
作者
Kim, RJ
Hillenbrand, HB
Judd, RM
机构
[1] Northwestern Univ, Sch Med, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA
[2] Northwestern Univ, Sch Med, Dept Med, Chicago, IL 60611 USA
[3] Northwestern Univ, Sch Med, Dept Biomed Engn, Chicago, IL 60611 USA
关键词
myocardial viability; MRI; spectroscopy; dobutamine; contrast agents;
D O I
10.1007/s000590050034
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Distinguishing between viable and non-viable myocardium is an important clinical issue. Several magnetic resonance (MR) techniques to address this issue have been proposed. Spectroscopy of phosphorus-31 and hydrogen-1 from creatine as well as imaging of sodium-23 and potassium-39 reflect information related to cellular metabolism. The spatial and temporal resolutions of these techniques are limited, however, by the small magnitude of the MR signal. Proton imaging techniques include examination of pathologic alterations in MR relaxation times (T-1 and T-2), wall thickness and thickening, cine MRI combined with low-dose dobutamine, first-pass contrast enhancement patterns, and delayed contrast enhancement patterns. Of the proton imaging approaches, cine MRI combined with low-dose dobutamine is supported by the largest body of clinical evidence supporting the hypothesis that the technique yields useful information regarding myocardial viability. Recent data suggest that delayed contrast enhancement examines the transmural extent of viable myocardium irrespective of contractile function and that this technique should also be considered in a clinical setting.
引用
收藏
页码:417 / 430
页数:14
相关论文
共 92 条
[1]   BIOCHEMICAL MARKERS OF MYOCARDIAL INJURY - IS MB CREATINE-KINASE THE CHOICE FOR THE 1990S [J].
ADAMS, JE ;
ABENDSCHEIN, DR ;
JAFFE, AS .
CIRCULATION, 1993, 88 (02) :750-763
[2]   PROGRESSIVE IMPAIRMENT OF REGIONAL MYOCARDIAL PERFUSION AFTER INITIAL RESTORATION OF POSTISCHEMIC BLOOD-FLOW [J].
AMBROSIO, G ;
WEISMAN, HF ;
MANNISI, JA ;
BECKER, LC .
CIRCULATION, 1989, 80 (06) :1846-1861
[3]   CHRONIC ISCHEMIC VIABLE MYOCARDIUM IN MAN - ASPECTS OF DEDIFFERENTIATION [J].
AUSMA, J ;
SCHAART, G ;
THONE, F ;
SHIVALKAR, B ;
FLAMENG, W ;
DEPRE, C ;
VANOVERSCHELDE, JL ;
RAMAEKERS, F ;
BORGERS, M .
CARDIOVASCULAR PATHOLOGY, 1995, 4 (01) :29-37
[4]   COMPARISON OF LOW-DOSE DOBUTAMINE GRADIENT-ECHO MAGNETIC-RESONANCE-IMAGING AND POSITRON EMISSION TOMOGRAPHY WITH [F-18] FLUORODEOXYGLUCOSE IN PATIENTS WITH CHRONIC CORONARY-ARTERY DISEASE - A FUNCTIONAL AND MORPHOLOGICAL APPROACH TO THE DETECTION OF RESIDUAL MYOCARDIAL VIABILITY [J].
BAER, FM ;
VOTH, E ;
SCHNEIDER, CA ;
THEISSEN, P ;
SCHICHA, H ;
SECHTEM, U .
CIRCULATION, 1995, 91 (04) :1006-1015
[5]  
BAER FM, 1994, HERZ, V19, P51
[6]   REGIONAL TC-99M-METHOXYISOBUTYL-ISONITRILE-UPTAKE AT REST IN PATIENTS WITH MYOCARDIAL INFARCTS - COMPARISON WITH MORPHOLOGICAL AND FUNCTIONAL PARAMETERS OBTAINED FROM GRADIENT-ECHO MAGNETIC-RESONANCE-IMAGING [J].
BAER, FM ;
SMOLARZ, K ;
THEISSEN, P ;
VOTH, E ;
SCHICHA, H ;
SECHTEM, U .
EUROPEAN HEART JOURNAL, 1994, 15 (01) :97-107
[7]   Comparison of dobutamine transesophageal echocardiography and dobutamine magnetic resonance imaging for detection of residual myocardial viability [J].
Baer, FM ;
Voth, E ;
LaRosee, K ;
Schneider, CA ;
Theissen, P ;
Deutsch, HJ ;
Schicha, H ;
Erdmann, E ;
Sechtem, U .
AMERICAN JOURNAL OF CARDIOLOGY, 1996, 78 (04) :415-419
[8]   Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization [J].
Baer, FM ;
Theissen, P ;
Schneider, CA ;
Voth, E ;
Sechtem, U ;
Schicha, H ;
Erdman, E .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (05) :1040-1048
[9]  
BEEN M, 1988, BRIT HEART J, V59, P1